Cardiogenesis Corporation (Pink Sheets: CGCP), today announced that it has submitted an IDE (Investigational Device Exemption) to the Food and Drug Administration to initiate a safety and feasibility trial for its PHOENIX System in patients with refractory angina. The PHOENIX handpiece is the first device specifically designed to allow physician-directed tissue stimulation and injections of biologic or pharmacologic agents to pre-determined areas of myocardium.
Bausch & Lomb today announced that it is launching the Crystalens® AO, the first aberration-free accommodating intraocular lens (IOL) with aspheric optics to cataract surgeons worldwide. The announcement follows the recent FDA approval of this newest Bausch & Lomb surgical product. The Crystalens AO, combined with the successful Crystalens HD and the Crystalens Five-0, will further establish Crystalens as the market leader in the premium IOL market.
Forecasts for the global market in systems, providing data for 2008 and estimates for 2009, and projections for the market and compound annual growth rates (CAGRs) from 2009 to 2014 An overview of medical laser applications, including cosmetic, diagnostic, surgical, and therapeutic A breakdown of the market by regions, and by technologies, including gas, dye, metal-vapor, and solid-state lasers.
Stryker Corporation (NYSE: SYK) today announced the closing of its previously announced acquisition of Ascent Healthcare Solutions, the market leader in the reprocessing and remanufacturing of medical devices in the U.S.
Upwards of 76 percent of patients with chronic rhinosinusitis (CRS) experienced significant quality of life (QOL) improvements after undergoing endoscopic sinus surgery (ESS), according to new research in the January 2010 issue of Otolaryngology – Head and Neck Surgery.
The prevalence of left-sided advanced colorectal neoplasms was lower in participants in a community setting, but not right-sided advanced neoplams, who had received a colonoscopy in the preceding 10 years, according to a new study published online December 30 in the Journal of the National Cancer Institute.
Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company looks forward to a prosperous 2010, following a solid year in 2009, due in great part to its MammoView(TM) instrument line.
JumpStart Inc., the Northeast Ohio venture development organization that accelerates the progress of high growth early-stage businesses, announces two JumpStart Ventures investments. Absorbent Materials Company LLC (dba ABSMaterials LLC), a company developing a novel, silica-based material that absorbs toxins in water, and MAX Endoscopy Inc., a medical device manufacturer using fiber optics to guide the treatment of hemorrhoids, each received investment commitments of $250,000.
Designer Cynthia Shapiro has recently announced the release of Cinzia Designs' latest eyewear and accessories collections for Spring 2010.
A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.